MeSH tree: F03.615.400.100
A new study suggests that Alzheimer's disease may be detected by brain imaging more than seven years earlier than previously assumed. Researchers from the Department of Psychology at the University of Oslo led the study, ...
Aug 19, 2026
0
7
For years, scientists have known that regular physical activity can help lower the risk of dementia. But new USC research suggests that it's not only the amount but also the activity's context—for work or for leisure—that ...
Aug 18, 2026
0
28
Exposure to common forms of outdoor air pollution may be linked to structural changes in brain regions that are especially vulnerable to Alzheimer's disease, according to a new study led by researchers from the USC Mark and ...
Aug 17, 2026
0
6
AI-based "tissue clocks" can estimate the biological age of human organs from histological images, researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Ludwig Boltzmann ...
Aug 14, 2026
0
40
A compound produced by bacteria in many people's digestive tracts increases the risk of developing Alzheimer's disease and speeds cognitive decline in dementia patients, making it a potential target for a treatment that could ...
Aug 13, 2026
0
784
Blood biomarkers may make it possible to detect changes seen in Alzheimer's disease without advanced brain imaging or cerebrospinal fluid tests. At the same time, much of the research behind today's biomarkers has been conducted ...
Aug 13, 2026
0
4
Women on regimens of estrogen-only menopausal hormone therapy are at reduced risk of Alzheimer's disease, a study by Stanford Medicine investigators has found. Because estrogen-only therapy is generally prescribed for women ...
Aug 13, 2026
0
6
Use of hormone therapy later in life was associated with a lower risk of developing dementia, according to a study published in Neurology.
Aug 12, 2026
0
10
Encephalitis is a serious condition in which an infection or autoimmune response triggers inflammation of the brain. The resulting swelling can disrupt normal brain function, causing neurological changes such as confusion, ...
People with both atrial fibrillation and Alzheimer's disease who are treated with modern NOAC blood-thinning medicines may experience a slower rate of cognitive decline. This is shown by a study from Karolinska Institutet ...
Aug 12, 2026
0
24
